HAMP and cancer: Serum hepcidin levels are affected by certain physiological conditions, such as erythropoietic activity and iron status [11, 17], as well as pathologies, including chronic inflammation and malignancies, in which there is defective iron utilization and a diminished erythropoietin response [18, 19].